1800010I iavi base award $810,077 FY20 cell line optimization and pre-master bank generation for SB 301, a vaccine for hepatitis b virus (HBV) TOVM20V24VB 2 IID can 8470036
Active Awarded Last action
- Contract number
- 75N93020F00003
- Awardee
-
International Aids Vaccine Initiative Inc. UEI ZEJBC8JQM3P5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,098,404
Award facts
- Contract value 100% obligated
- $1,098,404.00 Current and potential, with all options
- Completion date 80% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- New York, NY 10004, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $21,289 | |
| Supplemental Agreement for work within scope | $190,038 | |
| Change Order | $77,000 | |
| Original award | $810,077 |
About this award
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization focused on HIV vaccine development. The $1,098,404.00 cost-plus-fixed-fee contract provides funding for IAVI to perform cell line optimization and pre-master bank generation for SB 301, a vaccine candidate for hepatitis B virus (HBV). This work is being conducted under Task Order 2 of a larger indefinite delivery/indefinite quantity (IDIQ) contract vehicle with NIAID to support biopharmaceutical product development and preclinical/translational vaccine development for HIV and other infectious diseases. The contract does not have a set-aside designation.
Quick answers
Who was awarded contract 75N93020F00003?
75N93020F00003 was awarded to International Aids Vaccine Initiative Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 22, 2020.
How much is contract 75N93020F00003 worth?
The government has obligated $1,098,404 on 75N93020F00003.
Is contract 75N93020F00003 an order under another contract?
Yes. 75N93020F00003 is a delivery order under 75N93018D00010, an indefinite delivery contract.
Was contract 75N93020F00003 competed?
The extent of competition for 75N93020F00003 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award